Welcome
Dear Friends and Colleagues
On behalf of the Planning Committee we are delighted to introduce the Lupus Academy*, and welcome you to this meeting registration website, where you will find details of our inaugural meeting in Barcelona next spring, faculty and Continuing Medical Education programme information.
Our Planning Committee, of six international experts in Lupus, has endeavoured to provide an unparalleled scientific programme, which we believe will provide you with new ideas and enhanced enthusiasm for future interaction and discussion with your colleagues in Lupus.
The forthcoming Inaugural meeting of the Lupus Academy will provide you with valuable insight into advances in global research and clinical practice in Lupus and allied diseases. The scientific programme is designed to create a highly interactive forum with world-leading clinicians and scientists for the exchange of information and experiences in the management of Lupus across Europe.
The Lupus Academy will sponsor a limited number of delegates on a first come, first served basis. To apply for a sponsored place, please click here. For group registration and requests for additional information, please contact the Secretariat at secretariat@lupus-academy.org. Applications for sponsorsred places must be submitted before 31st January 2012.
We sincerely hope that you will be able to join us at the inaugural meeting of the Lupus Academy in Barcelona next spring (2012) for what promises to be one of the most refreshing and informative meetings on the Lupus calendar.
With kind regards,

Professor Roger A. Levy Lupus Academy Programme Director and Co-chairman |
Professor Ricard Cervera Lupus Academy Chairman |
|
Professor David Isenberg |
Professor Munther Khamashta |
Professor Sandra Navarra |
Professor Ronald van Vollenhoven |
*The Lupus Academy is a long-term initiative dedicated to improving patient outcomes in SLE through an interactive educational forum dedicated to sharing best clinical practice through the dissemination and discussion of clinical and basic scientific research about SLE and allied diseases.
